SecSonar.com

Teleflex Incorporated (TFX)

Teleflex Incorporated at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Teleflex Incorporated (TFX) is a Medical - Instruments & Supplies company based in US with a market capitalization of $5.7B. Revenue declined 34.6% year-over-year and the company generated $245.4M in free cash flow. This page tracks TFX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 14.1K employees · IPO Mar 17, 1980

Valuation

Valuation & price

$129.71 · as of May 17, 2026 · -6.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.83

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$139$120$100Jul 25Dec 25Jun 26Jul 7, 25$116.67Jul 9, 25$118.93Jul 11, 25$116.40Jul 15, 25$113.47Jul 17, 25$113.59Jul 21, 25$109.79Jul 23, 25$117.24Jul 25, 25$117.19Jul 29, 25$115.49Jul 31, 25$119.50Aug 4, 25$116.06Aug 6, 25$112.07Aug 8, 25$118.41Aug 12, 25$119.64Aug 14, 25$121.50Aug 19, 25$124.30Aug 21, 25$124.61Aug 25, 25$127.55Aug 27, 25$129.50Aug 29, 25$126.41Sep 3, 25$126.05Sep 5, 25$130.70Sep 9, 25$130.23Sep 11, 25$132.50Sep 15, 25$125.89Sep 17, 25$125.62Sep 19, 25$122.63Sep 23, 25$122.11Sep 25, 25$117.00Sep 29, 25$120.65Oct 2, 25$125.50Oct 6, 25$127.71Oct 8, 25$128.43Oct 10, 25$119.42Oct 14, 25$122.28Oct 16, 25$123.88Oct 20, 25$130.54Oct 22, 25$132.78Oct 24, 25$131.91Oct 28, 25$130.58Oct 30, 25$124.84Nov 3, 25$122.85Nov 5, 25$124.75Nov 7, 25$109.40Nov 11, 25$112.26Nov 14, 25$107.00Nov 18, 25$107.47Nov 20, 25$104.64Nov 24, 25$111.39Nov 26, 25$115.29Dec 1, 25$114.41Dec 3, 25$119.12Dec 5, 25$120.50Dec 9, 25$131.25Dec 11, 25$127.25Dec 15, 25$126.72Dec 17, 25$125.10Dec 19, 25$121.89Dec 23, 25$122.29Dec 26, 25$122.76Dec 31, 25$122.04Jan 5, 26$124.46Jan 7, 26$126.53Jan 9, 26$112.81Jan 13, 26$103.90Jan 15, 26$104.61Jan 20, 26$100.34Jan 22, 26$105.09Jan 26, 26$104.20Jan 28, 26$105.33Jan 30, 26$104.37Feb 3, 26$102.37Feb 5, 26$105.89Feb 9, 26$106.21Feb 11, 26$106.95Feb 17, 26$105.86Feb 19, 26$111.80Feb 23, 26$113.04Feb 25, 26$111.89Feb 27, 26$122.06Mar 3, 26$122.19Mar 5, 26$117.57Mar 9, 26$113.61Mar 11, 26$111.75Mar 13, 26$107.32Mar 17, 26$109.00Mar 19, 26$107.05Mar 23, 26$105.85Mar 25, 26$108.18Mar 27, 26$116.22Apr 1, 26$118.42Apr 6, 26$115.04Apr 8, 26$119.03Apr 10, 26$118.39Apr 14, 26$125.21Apr 16, 26$130.22Apr 20, 26$131.95Apr 22, 26$138.81Apr 24, 26$136.56Apr 28, 26$135.52Apr 30, 26$123.91May 4, 26$119.89May 6, 26$123.23May 8, 26$133.06May 12, 26$129.03May 15, 26$129.71May 19, 26$132.74May 21, 26$131.90May 26, 26$131.89May 28, 26$129.66Jun 1, 26$127.57Jun 3, 26$128.56Jun 5, 26$129.84Jun 9, 26$135.75Jun 11, 26$129.31Jun 15, 26$130.09Jun 17, 26$124.96Jun 22, 26$121.67Jun 24, 26$126.51Jun 30, 26$126.77
$100.3452-week range$138.81
Loading valuation history…

Fundamentals

Key fundamentals

$5.7B

Market cap

-34.6%

Revenue growth (YoY)

56.2%

Gross margin

$245.4M

Free cash flow (USD)

$2.3B

Net debt

-4.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.9BFY 2017$2.1BFY 2018$2.4BFY 2019$2.6BFY 2020$2.5BFY 2021$2.8BFY 2022$2.8BFY 2023$3.0BFY 2024$3.0BFY 2025$2.0B
$1.9B$2B

Free cash flow by year

2016 → 2025

FY 2016$355.3MFY 2017$349.0MFY 2018$356.6MFY 2019$336.8MFY 2020$345.7MFY 2021$579.8MFY 2022$263.0MFY 2023$419.2MFY 2024$509.3MFY 2025$245.4M
$355.3M$245.4M

Gross margin by year

2021 → 2025

FY 202155.1%FY 202254.9%FY 202355.4%FY 202455.9%FY 202556.2%
55.1%56.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt IssuanceJun 15, 2026Filing
  • 8-K eventStock Award GrantedJun 9, 2026Filing
  • 8-K eventDebt OfferingJun 2, 2026Filing
  • 8-K eventAdjusted EBITDA DisclosureJun 1, 2026Filing
  • 8-K eventCredit Agreement ExecutedMay 27, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCEO AppointmentApr 30, 2026Filing

Questions

Frequently asked questions

What is Teleflex Incorporated's market cap?

Teleflex Incorporated (TFX) has a market capitalization of $5.7B.

What is TFX's P/E ratio?

A meaningful P/E ratio is not available for TFX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TFX's price-to-book (P/B) ratio?

TFX trades at 1.83 times book value per share.

Are insiders buying TFX stock?

SEC Form 4 filings show no open-market insider buys at Teleflex Incorporated in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

STVN

Stevanato Group S.p.A.

$5.2B

AVTR

Avantor, Inc.

$6.4B

RGEN

Repligen Corporation

$7.1B

ATR

AptarGroup, Inc.

$7.4B

MMSI

Merit Medical Systems, Inc.

$3.8B

ICUI

ICU Medical, Inc.

$3.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.